世界の抗ホルモン療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antihormonal Cancer Therapies Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0394
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、抗ホルモン療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線、医薬品、手術、その他）、用途別市場規模（乳がん、前立腺がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・抗ホルモン療法の市場動向
・企業の競争状況、市場シェア
・抗ホルモン療法の種類別市場規模（放射線、医薬品、手術、その他）
・抗ホルモン療法の用途別市場規模（乳がん、前立腺がん、その他）
・抗ホルモン療法の北米市場規模2016-2027（アメリカ、カナダ）
・抗ホルモン療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗ホルモン療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗ホルモン療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗ホルモン療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Novartis、Pfizer、Sanofi、Takeda、Roche、Amgen、Samyang Biopharmaceuticals、Tolmar、Bluebird Bio、Bristol-Myers Squibb、Exelixis、Guardant Health、Illumina）
・結論

Antihormonal Cancer Therapy is a treatment with drugs, surgery, or radiation in order to block the production or action of a hormone. Antihormone therapy may be used in cancer treatment because certain hormones are able to stimulate the growth of some types of tumors.

Market Analysis and Insights: Global Antihormonal Cancer Therapies Market
The global Antihormonal Cancer Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antihormonal Cancer Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antihormonal Cancer Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antihormonal Cancer Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antihormonal Cancer Therapies market.

Global Antihormonal Cancer Therapies Scope and Market Size
Antihormonal Cancer Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antihormonal Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radiations
Drugs
Surgeries
Others

Segment by Application
Breast Cancer
Prostate Cancer
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Novartis
Pfizer
Sanofi
Takeda
Roche
Amgen
Samyang Biopharmaceuticals
Tolmar
Sanofi
Takeda
Exelixis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihormonal Cancer Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiations
1.2.3 Drugs
1.2.4 Surgeries
1.2.5 Others
1.3 Market by Application
1.3.1 Global Antihormonal Cancer Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antihormonal Cancer Therapies Market Perspective (2016-2027)
2.2 Antihormonal Cancer Therapies Growth Trends by Regions
2.2.1 Antihormonal Cancer Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antihormonal Cancer Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Antihormonal Cancer Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Antihormonal Cancer Therapies Industry Dynamic
2.3.1 Antihormonal Cancer Therapies Market Trends
2.3.2 Antihormonal Cancer Therapies Market Drivers
2.3.3 Antihormonal Cancer Therapies Market Challenges
2.3.4 Antihormonal Cancer Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antihormonal Cancer Therapies Players by Revenue
3.1.1 Global Top Antihormonal Cancer Therapies Players by Revenue (2016-2021)
3.1.2 Global Antihormonal Cancer Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Antihormonal Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antihormonal Cancer Therapies Revenue
3.4 Global Antihormonal Cancer Therapies Market Concentration Ratio
3.4.1 Global Antihormonal Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihormonal Cancer Therapies Revenue in 2020
3.5 Antihormonal Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Antihormonal Cancer Therapies Product Solution and Service
3.7 Date of Enter into Antihormonal Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antihormonal Cancer Therapies Breakdown Data by Type
4.1 Global Antihormonal Cancer Therapies Historic Market Size by Type (2016-2021)
4.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2022-2027)

5 Antihormonal Cancer Therapies Breakdown Data by Application
5.1 Global Antihormonal Cancer Therapies Historic Market Size by Application (2016-2021)
5.2 Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antihormonal Cancer Therapies Market Size (2016-2027)
6.2 North America Antihormonal Cancer Therapies Market Size by Type
6.2.1 North America Antihormonal Cancer Therapies Market Size by Type (2016-2021)
6.2.2 North America Antihormonal Cancer Therapies Market Size by Type (2022-2027)
6.2.3 North America Antihormonal Cancer Therapies Market Size by Type (2016-2027)
6.3 North America Antihormonal Cancer Therapies Market Size by Application
6.3.1 North America Antihormonal Cancer Therapies Market Size by Application (2016-2021)
6.3.2 North America Antihormonal Cancer Therapies Market Size by Application (2022-2027)
6.3.3 North America Antihormonal Cancer Therapies Market Size by Application (2016-2027)
6.4 North America Antihormonal Cancer Therapies Market Size by Country
6.4.1 North America Antihormonal Cancer Therapies Market Size by Country (2016-2021)
6.4.2 North America Antihormonal Cancer Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Antihormonal Cancer Therapies Market Size (2016-2027)
7.2 Europe Antihormonal Cancer Therapies Market Size by Type
7.2.1 Europe Antihormonal Cancer Therapies Market Size by Type (2016-2021)
7.2.2 Europe Antihormonal Cancer Therapies Market Size by Type (2022-2027)
7.2.3 Europe Antihormonal Cancer Therapies Market Size by Type (2016-2027)
7.3 Europe Antihormonal Cancer Therapies Market Size by Application
7.3.1 Europe Antihormonal Cancer Therapies Market Size by Application (2016-2021)
7.3.2 Europe Antihormonal Cancer Therapies Market Size by Application (2022-2027)
7.3.3 Europe Antihormonal Cancer Therapies Market Size by Application (2016-2027)
7.4 Europe Antihormonal Cancer Therapies Market Size by Country
7.4.1 Europe Antihormonal Cancer Therapies Market Size by Country (2016-2021)
7.4.2 Europe Antihormonal Cancer Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antihormonal Cancer Therapies Market Size (2016-2027)
8.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type
8.2.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application
8.3.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region
8.4.1 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antihormonal Cancer Therapies Market Size (2016-2027)
9.2 Latin America Antihormonal Cancer Therapies Market Size by Type
9.2.1 Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Antihormonal Cancer Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2027)
9.3 Latin America Antihormonal Cancer Therapies Market Size by Application
9.3.1 Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Antihormonal Cancer Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2027)
9.4 Latin America Antihormonal Cancer Therapies Market Size by Country
9.4.1 Latin America Antihormonal Cancer Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Antihormonal Cancer Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antihormonal Cancer Therapies Market Size (2016-2027)
10.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type
10.2.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application
10.3.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country
10.4.1 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Antihormonal Cancer Therapies Introduction
11.1.4 AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Antihormonal Cancer Therapies Introduction
11.2.4 Novartis Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antihormonal Cancer Therapies Introduction
11.3.4 Pfizer Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Antihormonal Cancer Therapies Introduction
11.4.4 Sanofi Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Antihormonal Cancer Therapies Introduction
11.5.4 Takeda Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Antihormonal Cancer Therapies Introduction
11.6.4 Roche Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Antihormonal Cancer Therapies Introduction
11.7.4 Amgen Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Samyang Biopharmaceuticals
11.8.1 Samyang Biopharmaceuticals Company Details
11.8.2 Samyang Biopharmaceuticals Business Overview
11.8.3 Samyang Biopharmaceuticals Antihormonal Cancer Therapies Introduction
11.8.4 Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.8.5 Samyang Biopharmaceuticals Recent Development
11.9 Tolmar
11.9.1 Tolmar Company Details
11.9.2 Tolmar Business Overview
11.9.3 Tolmar Antihormonal Cancer Therapies Introduction
11.9.4 Tolmar Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.9.5 Tolmar Recent Development
11.10 Bluebird Bio
11.10.1 Bluebird Bio Company Details
11.10.2 Bluebird Bio Business Overview
11.10.3 Bluebird Bio Antihormonal Cancer Therapies Introduction
11.10.4 Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.10.5 Bluebird Bio Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Antihormonal Cancer Therapies Introduction
11.11.4 Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Exelixis
11.12.1 Exelixis Company Details
11.12.2 Exelixis Business Overview
11.12.3 Exelixis Antihormonal Cancer Therapies Introduction
11.12.4 Exelixis Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.12.5 Exelixis Recent Development
11.13 Guardant Health
11.13.1 Guardant Health Company Details
11.13.2 Guardant Health Business Overview
11.13.3 Guardant Health Antihormonal Cancer Therapies Introduction
11.13.4 Guardant Health Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.13.5 Guardant Health Recent Development
11.14 Illumina
11.14.1 Illumina Company Details
11.14.2 Illumina Business Overview
11.14.3 Illumina Antihormonal Cancer Therapies Introduction
11.14.4 Illumina Revenue in Antihormonal Cancer Therapies Business (2016-2021)
11.14.5 Illumina Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antihormonal Cancer Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radiations
Table 3. Key Players of Drugs
Table 4. Key Players of Surgeries
Table 5. Key Players of Others
Table 6. Global Antihormonal Cancer Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antihormonal Cancer Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Antihormonal Cancer Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Antihormonal Cancer Therapies Market Share by Regions (2016-2021)
Table 10. Global Antihormonal Cancer Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Antihormonal Cancer Therapies Market Share by Regions (2022-2027)
Table 12. Antihormonal Cancer Therapies Market Trends
Table 13. Antihormonal Cancer Therapies Market Drivers
Table 14. Antihormonal Cancer Therapies Market Challenges
Table 15. Antihormonal Cancer Therapies Market Restraints
Table 16. Global Antihormonal Cancer Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Antihormonal Cancer Therapies Market Share by Players (2016-2021)
Table 18. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihormonal Cancer Therapies as of 2020)
Table 19. Ranking of Global Top Antihormonal Cancer Therapies Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Antihormonal Cancer Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Antihormonal Cancer Therapies Product Solution and Service
Table 23. Date of Enter into Antihormonal Cancer Therapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2016-2021)
Table 27. Global Antihormonal Cancer Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Antihormonal Cancer Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2016-2021)
Table 31. Global Antihormonal Cancer Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Antihormonal Cancer Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Antihormonal Cancer Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Antihormonal Cancer Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Antihormonal Cancer Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Antihormonal Cancer Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Antihormonal Cancer Therapies Product
Table 66. AstraZeneca Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Antihormonal Cancer Therapies Product
Table 71. Novartis Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Pfizer Company Details
Table 74. Pfizer Business Overview
Table 75. Pfizer Antihormonal Cancer Therapies Product
Table 76. Pfizer Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 77. Pfizer Recent Development
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Antihormonal Cancer Therapies Product
Table 81. Sanofi Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Takeda Company Details
Table 84. Takeda Business Overview
Table 85. Takeda Antihormonal Cancer Therapies Product
Table 86. Takeda Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 87. Takeda Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Antihormonal Cancer Therapies Product
Table 91. Roche Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Amgen Company Details
Table 94. Amgen Business Overview
Table 95. Amgen Antihormonal Cancer Therapies Product
Table 96. Amgen Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 97. Amgen Recent Development
Table 98. Samyang Biopharmaceuticals Company Details
Table 99. Samyang Biopharmaceuticals Business Overview
Table 100. Samyang Biopharmaceuticals Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 101. Samyang Biopharmaceuticals Recent Development
Table 102. Tolmar Company Details
Table 103. Tolmar Business Overview
Table 104. Tolmar Antihormonal Cancer Therapies Product
Table 105. Tolmar Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 106. Tolmar Recent Development
Table 107. Bluebird Bio Company Details
Table 108. Bluebird Bio Business Overview
Table 109. Bluebird Bio Antihormonal Cancer Therapies Product
Table 110. Bluebird Bio Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 111. Bluebird Bio Recent Development
Table 112. Bristol-Myers Squibb Company Details
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Antihormonal Cancer Therapies Product
Table 115. Bristol-Myers Squibb Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Exelixis Company Details
Table 118. Exelixis Business Overview
Table 119. Exelixis Antihormonal Cancer Therapies Product
Table 120. Exelixis Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 121. Exelixis Recent Development
Table 122. Guardant Health Company Details
Table 123. Guardant Health Business Overview
Table 124. Guardant Health Antihormonal Cancer Therapies Product
Table 125. Guardant Health Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 126. Guardant Health Recent Development
Table 127. Illumina Company Details
Table 128. Illumina Business Overview
Table 129. Illumina Antihormonal Cancer Therapies Product
Table 130. Illumina Revenue in Antihormonal Cancer Therapies Business (2016-2021) & (US$ Million)
Table 131. Illumina Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antihormonal Cancer Therapies Market Share by Type: 2020 VS 2027
Figure 2. Radiations Features
Figure 3. Drugs Features
Figure 4. Surgeries Features
Figure 5. Others Features
Figure 6. Global Antihormonal Cancer Therapies Market Share by Application: 2020 VS 2027
Figure 7. Breast Cancer Case Studies
Figure 8. Prostate Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Antihormonal Cancer Therapies Report Years Considered
Figure 11. Global Antihormonal Cancer Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Antihormonal Cancer Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antihormonal Cancer Therapies Market Share by Regions: 2020 VS 2027
Figure 14. Global Antihormonal Cancer Therapies Market Share by Regions (2022-2027)
Figure 15. Global Antihormonal Cancer Therapies Market Share by Players in 2020
Figure 16. Global Top Antihormonal Cancer Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihormonal Cancer Therapies as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Antihormonal Cancer Therapies Revenue in 2020
Figure 18. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2016-2021)
Figure 19. Global Antihormonal Cancer Therapies Revenue Market Share by Type (2022-2027)
Figure 20. North America Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Antihormonal Cancer Therapies Market Share by Type (2016-2027)
Figure 22. North America Antihormonal Cancer Therapies Market Share by Application (2016-2027)
Figure 23. North America Antihormonal Cancer Therapies Market Share by Country (2016-2027)
Figure 24. United States Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antihormonal Cancer Therapies Market Share by Type (2016-2027)
Figure 28. Europe Antihormonal Cancer Therapies Market Share by Application (2016-2027)
Figure 29. Europe Antihormonal Cancer Therapies Market Share by Country (2016-2027)
Figure 30. Germany Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antihormonal Cancer Therapies Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Antihormonal Cancer Therapies Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Antihormonal Cancer Therapies Market Share by Region (2016-2027)
Figure 40. China Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antihormonal Cancer Therapies Market Share by Type (2016-2027)
Figure 48. Latin America Antihormonal Cancer Therapies Market Share by Application (2016-2027)
Figure 49. Latin America Antihormonal Cancer Therapies Market Share by Country (2016-2027)
Figure 50. Mexico Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antihormonal Cancer Therapies Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Antihormonal Cancer Therapies Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Antihormonal Cancer Therapies Market Share by Country (2016-2027)
Figure 56. Turkey Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Antihormonal Cancer Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 65. Amgen Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 66. Samyang Biopharmaceuticals Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 67. Tolmar Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 68. Bluebird Bio Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 70. Exelixis Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 71. Guardant Health Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 72. Illumina Revenue Growth Rate in Antihormonal Cancer Therapies Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界のがん治療市場規模・現状・予測（2021年-2027年）

Global Cancer Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z1076 2021年4月 98Pages
QYResearch社発行の本調査資料では、がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫学的・ワクチンアプローチ、抗増殖性アプローチ、光線力学療法、遺伝子治療アプローチ、細胞周期・アポトーシスアプローチ）、用途別市場規模（病院用...

世界の精密がん治療市場規模・現状・予測（2021年-2027年）

Global Precision Cancer Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z4743 2021年4月 93Pages
QYResearch社発行の本調査資料では、精密がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、免疫療法、標的療法、モノクローナル抗体療法、遺伝子療法）、用途別市場規模（病院、診断センター、腫瘍クリニック、研究機関）、主要...

世界の子宮頸がん治療法・診断市場規模・現状・予測（2021年-2027年）

Global Therapies and Diagnostics for Cervical Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z5619 2021年4月 98Pages
QYResearch社発行の本調査資料では、子宮頸がん治療法・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パパニコロウ塗抹検査、コルポスコピー検査、ECC手順）、用途別市場規模（製薬会社、病院及び診療所、民間及び政府研究所、学術機関）、...

世界のB細胞成熟抗原（BCMA）標的療法市場規模・現状・予測（2021年-2027年）

Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z0724 2021年4月 97Pages
QYResearch社発行の本調査資料では、B細胞成熟抗原（BCMA）標的療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（二重特異性抗体、抗体薬物複合体、キメラ抗原受容体T細胞）、用途別市場規模（肝臓がん、呼吸器がん、脳腫瘍、その他）、主要...

世界の再生医療市場規模・現状・予測（2021年-2027年）

Global Regenerative Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z4972 2021年4月 94Pages
QYResearch社発行の本調査資料では、再生医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種移植片、異種移植片、同種移植片）、用途別市場規模（軟部組織修復、心臓血管、歯科、整形外科、中枢神経系疾患治療、その他）、主要地域別市場規模（...

世界の顔面紅斑療法市場規模・現状・予測（2021年-2027年）

Global Facial Erythema Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z2301 2021年4月 91Pages
QYResearch社発行の本調査資料では、顔面紅斑療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の子宮内膜症治療市場規模・現状・予測（2021年-2027年）

Global Endometriosis Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z2158 2021年4月 92Pages
QYResearch社発行の本調査資料では、子宮内膜症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン避妊薬、ゴナドトロピン放出ホルモン（Gn-RH）アゴニスト、プロゲスチン療法、アロマターゼ阻害剤）、用途別市場規模（病院、クリニッ...

世界のオリゴヌクレオチドベース治療法市場規模・現状・予測（2021年-2027年）

Global Oligonucleotide-based Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z4250 2021年4月 90Pages
QYResearch社発行の本調査資料では、オリゴヌクレオチドベース治療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アンチセンスオリゴヌクレオチド、アプタマー、その他）、用途別市場規模（神経筋疾患、肝静脈閉塞症、その他）、主要地域別市場規...

世界の自家幹細胞ベース治療法市場規模・現状・予測（2021年-2027年）

Global Autologous Stem Cell Based Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z0526 2021年4月 93Pages
QYResearch社発行の本調査資料では、自家幹細胞ベース治療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞）、用途別市場規模（神経変性疾患、自己免疫疾患、心血管疾患）、主要地域別市場規模（北米、ア...

世界の変形性関節症用再生療法市場規模・現状・予測（2021年-2027年）

Global Regenerative Therapies for Osteoarthritis Market Size, Status and Forecast 2021-2027
QYR2104Z4971 2021年4月 95Pages
QYResearch社発行の本調査資料では、変形性関節症用再生療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細胞療法、組織工学、遺伝子治療）、用途別市場規模（病院、外来手術センター、整形外科クリニック、研究機関）、主要地域別市場規模（北米...

世界のがん治療市場規模・現状・予測（2021年-2027年） Cancer therapy describes the treatment of cancer in a patient, often with surgery, chemotherapy and/or radiotherapy. Targeted therapies are also available for some cancer types. A cancer patient might receive many different types of therapy, including those aimed at relieving the symptoms of cancer,…
世界の精密がん治療市場規模・現状・予測（2021年-2027年） Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormali…
世界の子宮頸がん治療法・診断市場規模・現状・予測（2021年-2027年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
世界の乳がん用ジェネリック医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Generic Drugs Market The global Breast Cancer Generic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…